XGN - Bernstein sees 19% upside in Amgen in premarket analyst action October, 14 2019 08:24 AM Exagen Inc. Allergan (NYSE:AGN) resumed with Market Perform rating and $180 (7% upside) price target at Bernstein.More news on: Allergan plc, Amgen Inc., Biogen Inc., Healthcare stocks news, Stocks on the move, , Read more ...